% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • rosemariecorbin rosemariecorbin Jan 25, 2012 9:52 AM Flag

    ILMN deal GHDX next?

    biotech highlighting life sciences.I think everyone agrees GHDX is a very attractive candidate.I did post GHDX wants to stay single but if the price is right,the Baker Bros will kindly oblige

    "Last night, Roche (ROG VX, OW, covered by JPM analyst Alexandra Hauber)
    announced a hostile, all-cash $44.50 per share tender offer for Illumina (ILMN) that was described by Roche as “full and fair”. In our view, as with previous Roche hostile deals (including DNA, VMSI), this offer is likely a starting point, and we think it is highly unlikely that many investors will tender at a 44% discount to the stock’s 52-
    week high. With technology leadership and the potential for open-ended growth,Illumina remains an extremely attractive asset, and we think the stock is likely to command a larger premium; we increase our Dec 2012 price target on ILMN to $70."

29.91-0.04(-0.13%)Oct 26 4:00 PMEDT